Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Okta, Inc. (OKTA) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance

Okta, Inc.Trade
Roivant Sciences Ltd. Common SharesTrade

Price performance (Past 24H)

Key statistics

Okta, Inc. vs Roivant Sciences Ltd. Common Shares — how do they compare? Okta, Inc. trades at $221.23 (market cap $38.11B), while Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $25.09B). The key difference: Okta, Inc. is the larger of the two by market cap, and Okta, Inc. is trading nearer its 52-week high, Roivant Sciences Ltd. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Okta, Inc. for 44 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.

OKTAROIV
Market Cap
$38.11B$25.09B
Volume
2,259,2935,738,571
Sector
TechnologyHealth
52-Week High
$220.21$41.81
52-Week Low
$62.93$16.04
Typical Hold Time
44 Days0 Days
Enterprise Value
$35.86B$21.36B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Okta, Inc.

OKTA trades at $220.21, up 0.7% with strong technical momentum and bullish moving averages. The company shows improving fundamentals with revenue growth from $2.3B to $2.6B and a return to profitability in 2025. Recent earnings beats and positive analyst sentiment (73.6% buy ratings) support the bullish case, though high valuation multiples and insider selling present cautionary notes.

Outlook remains positive with AI security initiatives driving growth potential, but investors face valuation risks at current levels. The stock trades above consensus price target, suggesting limited near-term upside despite strong operational improvements and market positioning in the cybersecurity sector.

Roivant Sciences Ltd. Common Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

OKTA
70% Buy30% Sell
Avg holding period · 44 Days
ROIV
100% Buy0% Sell
Avg holding period · 0 Days

About Okta, Inc.

Okta is a cloud-native security company that focuses on identity and access management. The San Francisco-based firm went public in 2017 and focuses on two key client stakeholder groups: workforces and customers. Okta's workforce offerings enable a company's employees to securely access its cloud-based and on-premises resources. The firm's customer offerings allow its clients' customers to securely access the client's applications.

Read more on OKTA →

About Roivant Sciences Ltd. Common Shares

Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.

Read more on ROIV →